Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Person › Details

Michael Gamber (Merck KGaA)

Gamber, Michael (Merck (DE) 201507 Head of Merck Innovation Center)


Organisation Organisation Merck KGaA
  Group Merck (DE) (Group)
Products Product pharmaceutical

Merck KGaA. (7/30/15). "Press Release: Merck Announces Application Period for Start-ups. Candidates Can Apply until August 14, 2015 – Merck Donates € 25,000 as a Silent Participant to the Start-ups". Darmstadt.

Merck, a leading company for innovative, top-quality high-tech products in healthcare, life science and performance materials, is calling for national and international start-ups to apply for funding of innovative ideas by August 14, 2015.

The Accelerator program is aimed at young companies in the healthcare, life science, performance materials, and IT sectors. The program will run for three months, in which at least three selected start-ups will receive strategic and operational advice, as well as financial support of € 25,000 in the form of a silent participation. The program does not foresee an equity interest in the companies receiving funding, nor influence over their operational and strategic management. The first three start-ups are supposed to move into the newly built, modular Innovation Center in Darmstadt, from September 14, 2015, on.

In addition to providing financial and infrastructure assistance, Merck will offer to coach the start-ups also supported by mentors and enable them to participate in several trainings. At the end of the three months, the companies will be part of Merck's start-up network.

"Building up an alumni network is one of the long-term goals," said Michael Gamber, who heads Merck’s Innovation Center. "We want to provide a home for our start-ups, also beyond the Accelerator program, and continue to collaborate closely with them."

Interested parties can find more information on this website and apply until August 14.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website Please go to to register online, change your selection or discontinue this service.

Merck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials – and generated sales of € 11.3 billion in 2014. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials

Record changed: 2020-06-26


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Michael Gamber

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top